These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28243980)

  • 61. Plasma nuclear factor kappa B and serum peroxiredoxin 3 in early diagnosis of hepatocellular carcinoma.
    Ismail S; Mayah W; Battia HE; Gaballah H; Jiman-Fatani A; Hamouda H; Afifi MA; Elmashad N; Saadany SE
    Asian Pac J Cancer Prev; 2015; 16(4):1657-63. PubMed ID: 25743848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
    Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
    Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H; Li B; Li Z; Wei Q; Ren L
    BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.
    Diaz-Sanchez A; Matilla A; Nuñez O; Rincon D; Lorente R; Lo Iacono O; Merino B; Hernando A; Campos R; Clemente G; Bañares R
    Ann Hepatol; 2013; 12(2):236-47. PubMed ID: 23396735
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.
    Abu El Makarem MA; Abdel-Aleem A; Ali A; Saber R; Shatat M; Rahem DA; Sayed D
    Ann Hepatol; 2011; 10(3):296-305. PubMed ID: 21677331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
    Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
    Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
    Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
    J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma.
    Jeng JE; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Tumour Biol; 2014 Apr; 35(4):3689-98. PubMed ID: 24375326
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
    Gray J; Chattopadhyay D; Beale GS; Patman GL; Miele L; King BP; Stewart S; Hudson M; Day CP; Manas DM; Reeves HL
    BMC Cancer; 2009 Aug; 9():271. PubMed ID: 19656391
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
    Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    Liu X; Guo R; Xu Y
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):463-470. PubMed ID: 34280008
    [No Abstract]   [Full Text] [Related]  

  • 77. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis.
    Khan IM; Gjuka D; Jiao J; Song X; Wang Y; Wang J; Wei P; El-Serag HB; Marrero JA; Beretta L
    Cancer Prev Res (Phila); 2021 Jun; 14(6):667-674. PubMed ID: 33685927
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma.
    El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369
    [TBL] [Abstract][Full Text] [Related]  

  • 79. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.
    Jiang C; Zhang Y; Yu HF; Yu XT; Zhou SJ; Tan YF
    Tumour Biol; 2012 Dec; 33(6):2167-72. PubMed ID: 22941466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.